Raziel Therapeutics Ltd Overview
Company Headquarters: Hamerkaz, Israel
Founded: 2012
Workforce: ~10
Company Working: Raziel Therapeutics Ltd is a clinical-stage pharmaceutical company which is developing injectable therapeutics for the treatment of aesthetics and a variety of fat disorders. The company provide a single injection treatment into subcutaneous fat which is cause fast fat cell death at injection site as well as empowering medical professionals to enable patients with a better treatment fat reduction for long time periods without noninvasive procedure. The company has strong business presence in Israel.
Strategy
Raziel Therapeutics Ltd is focused on treating conditions such as Dercum’s disease. In addition, the company has developed a new chemical entity (NCE) which is known as RZL-12. RZL-12 is injected into subcutaneous fat to convert white adipose tissue (WAT) into brown adipose tissue-like to treat obesity and overweight disease. Moreover, the company continuously strategize for the development of advance therapeutics for the treatment of Dercum’s disease.
